Skip to content
Aperlena

Spain - Pharmaceutical products - Framework agreement for the supply of medicines without competition for hospitals of the Cantabrian Health Service

Original España - Productos farmacéuticos - Acuerdo Marco para el Suministro de Medicamentos sin competencia para los Hospitales del Servicio Cántabro de Salud (Principios activos Blinatumomab, Carfilzomib, Sotorasib, Romiplostim, Etelcalcetida hidrocloruro, Evolocumab, Inebilizumab, panitumumab)

Awarded Contract award

Key facts

Awarded
Winner
AMGEN S.A.
Estimated value
€26,327,388
Where
Spain Cantabria
Procedure
Negotiated procedure The buyer selects candidates, then negotiates the offers before choosing. Full entry Above the EU threshold A contract large enough that EU-wide rules apply and it must be published on TED. Full entry
CPV code The EU's common vocabulary for what is being bought: an eight-digit code every notice carries. Full entry
33600000 Pharmaceutical products
Original language
Spanish
Source
via TED - Tenders Electronic Daily (Publications Office of the EU), verified 21 hours ago
Notice number
657935-2026
Watch this tender

Bidding is closed. An award or a correction on this notice: an email when the register sees it. Log in

  1. Awarded
  2. Published

Summary

Machine-generated summary

The Cantabrian Health Service in Spain awarded a framework agreement for the supply of medicines without competition for its hospitals. The agreement covers active ingredients including Blinatumomab, Carfilzomib, Sotorasib, Romiplostim, Etelcalcetide hydrochloride, Evolocumab, Inebilizumab and panitumumab, sold under names such as Blincyto, Lumykras, Nplate, Parsabiv, Uplizna and Vectibix. The contract was won by AMGEN S.A. with an estimated value of EUR 26,327,387.52. The award date was 2026-08-21.

Description

Acuerdo Marco para el Suministro de Medicamentos sin competencia para los Hospitales del Servicio Cántabro de Salud (Principios activos Blinatumomab, Carfilzomib, Sotorasib, Romiplostim, Etelcalcetida hidrocloruro, Evolocumab, Inebilizumab, panitumumab) Lote 1. Blincyto (Blinatumomab); Lote 3. Lumykras (Sotorasib); Lote 4. Nplate (Romiplostim); Lote 5. Parsabiv (Etelcalcetida Hidrocloruro); Lote 7. Uplizna (Inebilizumab); Lote 8. Vectibix (Panitumumab)

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 21 hours ago

More from this buyer

Full buyer profile

3 open tenders right now

Recent awards

Similar tenders

1

day left

Supply of Regadenoson

Spain Medical equipment & pharmaceuticals Centro Nacional de Investigaciones Cardiovasculares Carlos I...

€56,440

est. value

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€11,379,775
9,937 open across Europe right now 131% above sector average
Buyer track record on Aperlena
481 notices tracked · 449 awarded
€61,006,781 in awarded contracts

Never miss a tender like this

864 new notices in Medical equipment & pharmaceuticals in Spain in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Index

Close
Log in

Language